1. Home
  2. GKOS vs AUB Comparison

GKOS vs AUB Comparison

Compare GKOS & AUB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$141.22

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo Atlantic Union Bankshares Corporation

AUB

Atlantic Union Bankshares Corporation

HOLD

Current Price

$38.02

Market Cap

5.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
AUB
Founded
1998
1902
Country
United States
United States
Employees
N/A
3064
Industry
Medical/Dental Instruments
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
5.1B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
GKOS
AUB
Price
$141.22
$38.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
8
Target Price
$126.92
$41.88
AVG Volume (30 Days)
642.1K
936.8K
Earning Date
04-29-2026
04-21-2026
Dividend Yield
N/A
3.98%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$507,442,000.00
N/A
Revenue This Year
$23.32
$29.16
Revenue Next Year
$27.43
$4.59
P/E Ratio
N/A
$19.68
Revenue Growth
32.33
N/A
52 Week Low
$73.16
$28.11
52 Week High
$145.50
$42.18

Technical Indicators

Market Signals
Indicator
GKOS
AUB
Relative Strength Index (RSI) 73.45 55.08
Support Level $80.14 $34.59
Resistance Level N/A $39.26
Average True Range (ATR) 4.95 0.88
MACD 1.69 -0.05
Stochastic Oscillator 86.28 42.93

Price Performance

Historical Comparison
GKOS
AUB

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About AUB Atlantic Union Bankshares Corporation

Atlantic Union Bankshares Corp is a financial and bank holding company based in the U.S. Through its community bank subsidiary and non-bank financial services affiliates, the company provides financial services, including banking, trust, and wealth management. It offers consumers and businesses a wide range of banking and related financial services, including checking, savings, certificates of deposit, and other depository services, as well as loans for commercial, industrial, residential mortgage, and consumer purposes. The company operates through two reportable operating segments: Wholesale Banking and Consumer Banking, with corporate support functions such as corporate treasury and others included in Corporate Other. It derives maximum revenue from the Wholesale Banking segment.

Share on Social Networks: